chrisvoncsefalvay/vaers-outcomes huggingface dataset:
3/20, admitted day after covid vaccine with AMS. Patient presented to ED with HA and confusion. After speaking with family it turns out patient with history of dementia. Symptomatic treatment and IV fluids given with good improvement in symptoms.  On recheck the disorientation and altered mentation seem to have greatly improved.  The CT scan of the head shows no tumor or bleed but does have nonspecific abnormalities.  There is atherosclerosis.  Severity of symptoms are concerning as they are completely unexplained with no trauma no signs of infection no other new exposure or carbon monoxide toxicity. Patient admitted. No focal neuro deficits-ordered mri brain however cancelled given history of dementia. Patient did have elevated ESR that was elevated, she had HA (not c/w TA). Patient is stable, appropriate for discharge to home the morning of 3/21/2021.
Patient given varicella due to low titers. Chickenpox lesions 1 1/2 days later (wife had chicken pox).
injection site side effect - sore arm with pain. Not able to lift for few days. Still hearts after 30 days, numbness in fingers because of pain.  Aleve for 3 days by prescriber  Aleve is not helping with pain and still bothering because of pain  X-rays done by doctor and recommend physical therapy to rule our rotator  cuff
Vomiting, Blurred Vision, Hard time catching my breath, numbness in arms, chest pressure, ear pain, headache,  muscle aches, fever, dizziness for about 3 hours starting at 11:00 p.m. Ambulance was called around 2:00 a.m.  taken to  Hospital  Seen by  MD  tests:  Imaging XR CHEST AP PORTABLE  MD Apr 12, 2021 The result is abnormalLab  CBC WITH PLATELET AND DIFFERENTIAL  MD Apr 12, 2021 The result is abnormalLab  COMPREHENSIVE METABOLIC PANEL  MD Apr 12, 2021  Lab  PT-PTT  MD Apr 12, 2021  Lab TROPONIN  MD Apr 12, 2021  Lab CKMB W/TOTAL CPK  MD Apr 12, 2021  Lab P-NATRIURETIC PEPTIDE, MD Apr 12, 2021 The result is abnormalLab  MAGNESIUM  MD Apr 12, 2021  Lab ESTIMATED GLOMERULAR FILTRATION RA  MD Apr 12, 2021  Lab SARS-CoV-2 RNA RT-HDA  MD Apr 12, 2021  Lab POCT PERFORM URINE PREGNANCY  MD Apr 12, 2021  Pt seen and examined. Workup ordered. IVB, zofran, pepcid, toradol 15mg iv ordered. Reassess.   Magnesium 1.4. repletion ordered.   covid19 -ve.   Upon reevaluation, pt feels better. VSS. Pt is clinically stable for d\c from ER.   D\c to home per d\c instructions Strict d\c instructions and parameters when to RTER d\w pt, all of which pt verbalized understanding and agreement.
Information has been received from a physician concerning a female who on 02-JUL-2009 was vaccinated intramuscularly with a dose of GARDASIL (lot no. not reported). After vaccination, on an unknown date, the patient started experiencing flu like symptoms and had swelling in her groin area. Subsequently, the patient recovered. Follow     up information has been received from a licensed practical nurse who regarding a 17 year old female at 134 pounds weight and 52 inches with drug allergies to AUGMENTIN, OMNICEF, BACTRIM who on 02-JUL-2009 was vaccinated intramuscularly in the right deltoid with her first dose of GARDASIL (Lot#661954/1131X) at 11:50 am. It was reported that 5 - 7 days following GARDASIL first injection on 07-JUL-2009, the patient experienced cervical lymphadenopathy, sore throat, headache, dizziness, fever (TM 102.3), hives, nausea, diarrhea and loss of appetite. On an unknown date some symptoms dissipated but the patient had prolonged (10 weeks) of out cervical lymphadenopathy, fatigue and dizziness. Extensive work-up by a hematologist, ENT (ears, nose, and throat), infectious disease and endocrinology. At the time of the report the patient was improving. the liscensed practical nurse considered the patient's experience to be disabling. Additional information has been requested. 10/19/2009 records from PCP, ENT, Hematologist  and Endocrinologist visits. Patient 5 days post vaccine had sx of: cervical lymphadenopathy, headache, sore throat, fever, urticaria, nausea, diarrhea, dizziness , malaise, fatigue and anorexia. Initially dx'd with strep pharyngitis and was on ABX x 2 and Medrol dose pak,  lymph node size decreased at first but then rebounded and have continued to enlarge since then. PE notes tender , mobile bilateral enlarged cervical lymph nodes appox 2-3 cm. ED visit 9/10/2009: sx frequent urination, hematuria. DC Dx UTI, Tx'd with ABX/Pyridium. Final Dx: Hashimoto's Thyroiditis, Viral lymphadenitis with mono-like illness.  Tx: modify activities/rest. 11/5/2009 records from OB-GYN MD 5-8/2009, with c/o's amenorrhea
Patient reports feeling dizzy (+ nauseous) about 23 hr after first dose. This lasted about 20 minutes.
My taste and smell was enhanced to the point that the smell made me want to throw up. It went away after about 5 months.
For five hours up after vaccine administration patient had cried, not consoled. Parents are first time paretns so difficult to tell if was prolonged crying or normal crying after a vaccine.
A 38-year-old college student was given MMR vaccine on 4/20/23 on Left upper arm at Health Clinic. On 4/28/23, patient reports by email that vaccine site has an itchy sensation and patient provided photo by email. Patient was contacted on 4/28/23 for video appointment, but patient was not able to participle. Patient was schedule an appointment on 5/1/23 at Health Clinic with NP for possible allergic reaction. NP evaluated the possible vaccine reaction on LUA. Lesion improved without any visit to ED, no complaint of SOB, diffuse rashes/hives. Patient treated the lesion with Neosporin ointment.
Black out, paleness, hotheadedness, and dizziness.  She felt while standing and hit the back of her head.  She recovered after 1 minute that she collapse and was unable to remember anything that happened, but was was able to remember her name.  She was then given Epinephrine 0.1 sbq.
Received the Covid-19 vaccine. She reports symptoms of Other: Shortness of breath and "feeling funny.". I have observed patient feeling anxious and uncomfortable.   Treatment/intervention /vitals taken:  B/P 124/82, pulse 104, RR 16, Oximetry 98%.  Recheck p- 82, oximetry 100%. Lungs were clear bilaterally.  Patient stating that she was feeling much better.  Offered her water to drink.  Staff remained with patient until she was feeling comfortable enough to leave.  When leaving, she stated that she was fine and needed no assistance.  Ambulatory.Agency report submitted: yes Agency Report number:
Headache, Myalgia, Rash, localized - Erythema, edema, numbness/timgling Narrative:
Fever up 100.6 for 12 hours, headache, body ache, joint ache, lethargic, vomiting.  Started 12 hours after the vaccine was received and lasted for the next 24 hours.
A little headache; Low grade fever.; This is a spontaneous report from a non-contactable other healthcare professional. This reporter reported similar events for two patients. This is the second of two reports.  A 6-decade-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2ND DOSE, SINGLE DOSE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that in the second dose, side effects and symptoms are a little bit intense which included a little headache and low grade fever. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021493997 Same reporter and product, similar events, different patients
right side lymph swelling; right ear pain; could not hear out of her right ear; gently touch the right side of her head and she is in pain; Pain; This is a spontaneous report from a contactable consumer or other non hcp (parent). A 12-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on 12Aug2021 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced right side lymph swelling, right ear pain on 12Aug2021 while could not hear out of her right ear, gently touch the right side of her head and she is in pain, pain on an unspecified date in Aug2021. It was reported that, the mother of the patient on the line calling about the Pfizer Covid-19 vaccine and reported that her daughter received her first dose 12Aug2021. Within 24 hours her daughter had lymph node swelling and what she thought was normal ear pain on the right side. They applied heat and ice. She took her daughter to the doctor on 18Aug2021. The doctor looked in her ears and the patient could not hear out of the right ear. He referred them to the ER. They waited for 2 hours in the ER and they sent her home because it was not an emergency and she was referred to her primary care. The caller reported that her daughter cannot hear anything out of her right ear. Someone was taking her daughter to the clinic to get revaluated. She called the CDC and they referred her to the ER. The patient was in a lot of pain and you can barely touch the side of her neck. Therapeutic measures were taken as a result of events. The outcome for all events was unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Chills; generalized muscle cramping especially in back and chest; site pain; This is a spontaneous report from a contactable other HCP. A 24-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3302), via an unspecified route of administration on arm left from 16Jan2021 08:30 to 16Jan2021 08:30 at SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date. On 16Jan2021 at 20:00, the patient experienced chills, generalized muscle cramping especially in back and chest and site pain. The patient was not pregnant at the time of the report. Outcome of the events was recovering.  .
This spontaneous report was received from a Nurse refers to a 18 year old patient. On 20-MAR-2014, the patient was vaccinated with improperly stored VARIVAX (Merck) Lot # H014074 (dose, route and frequency were not reported). The nurse reported that on 24-OCT-2013, VARIVAX (Merck) was stored for -13.9 C for 8 hours. On 29-OCT-2013, the VARIVAX (Merck) was stored for -12.8 C for 4 hours. On 14-NOV-2013, the VARIVAX (Merck) was stored for -11.4 C for 1.5 hours. On 26-MAR-2014, the VARIVAX (Merck) was stored for -14.7 C for 1.5 hours. On 14-MAY-2014, the VARIVAX (Merck) was stored for -13.8 C for a total of 5 hours. Since the overall average for VARIVAX (Merck) was below -15 C, these cumulative excursions of -11.4C for 20 hours is supported. No adverse effect has been reported. No further information was provided. This case is linked to the case 1405USA015833, 1405USA015834, 1405USA015835, 1405USA015836, 1405USA015837, 1405USA015838, 1405USA015840, 1405USA015841, 1405USA015842 and 1405USA008798 (same reporter link). Additional information has been requested.
Developed a rash on both inner forearms with pruritis treated with benadryl and calamine spray.
No additional AE; HCP reported VARIVAX was administered after a temperature excursion.; This spontaneous report has been received from other health care professional, regarding to 12 months female patient. The patient's pertinent medical history, concurrent conditions, concomitant medications, and previous drug reactions or allergies were not reported.   On 25-JAN-2023, the patient was vaccinated with improperly stored doses of varicella virus vaccine live (Oka/Merck) (VARIVAX) injection (lot number W008711 which has been verified to be valid, expiration date reported and validated as 14-MAR-2024) (strength, dose, vaccination scheme frequency, route of administration, and anatomical sites of injection were not reported) Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II)  and Hepatitis A Vaccine, Inactivated (VAQTA) (strengths, doses, vaccination scheme frequencies, routes of administration, anatomical sites of injection, lot numbers, and expiration dates were not reported). All of the vaccines were administered as prophylaxis.   Administered doses were stored at a temperature of -10.5 degrees Celsius (C) during a time frame of 1 hour and 34 minutes. There was no previous temperature excursion.  No additional adverse events were reported in the patient.  This is one of several reports received from the same reporter.
Mother reported that childs left arm was ok in the morning but at 4pm the arm was swollen, red and hot to the touch from the elbow to the shoulder. Denied any fever at that time. Child was taken to Hospital and seen by Dr.  Child started on Childrens Benadryl 1 teaspoon as needed and Keflex 1 teaspoon twice a day for 7 days.  Mother reports that emergency room physician was unsure if it was a reaction to the vaccine or an infection.  Was seen in the emergency room again the next day for follow up and the swelling was going down according to the mother.
Patient was given a dose of Hep A meant for patients ages 0-18 years; patient was 19 years old at the time of the vaccine.
Tested Positive for COVID-19; Tested Positive for COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 35-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (medically significant) with onset 24Apr2022, outcome "recovered" (Apr2022), DRUG INEFFECTIVE (medically significant) with onset 24Apr2022, outcome "unknown" and all described as "Tested Positive for COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (24Apr2022) Positive, notes: COVID test type post vaccination: Nasal swab. Therapeutic measures were not taken as a result of covid-19, drug ineffective. Clinical Course: Prior to vaccination, the patient had no diagnosed with COVID-19 and  Since the vaccination, the patient tested positive for COVID-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
09/04/22 presents to ED for "hand injury (motor skills issue)". PMHx of "DVT and PE"
Information has been received from a doctor of pharmacy concerning a 97 year old female patient who on an unspecified date was vaccinated in the nursing home with a dose of PNEUMOVAX 23 (Lot# not reported) and then 30 days later in another hospital the patient was vaccinated with another dose of PNEUMOVAX 23 (Lot# not reported). Subsequently, on an unspecified date, the patient was hospitalized and the reason for admission was unknown. The pharmacist mentioned that the patient was not having any reactions from receiving PNEUMOVAX 23, 30 days apart. At the time of the report, the patient's outcome was unknown. No further information is available.
Pt. discovered warm hard lump to (L) deltoid. Evaluation shows a 14 x 17 cm hard, raised, warm area, surrounding injection site, pt. was given 25mg BENADRYL, pt. was monitored, for 30 minutes. Will have patient follow-up 12/10/15 - improved induration decreased to 12x12 cm.
On 26DEC ( 5 days after first injection), he started experiencing pain and weakness in the  Right deltoid radiating down to the fingertips . Within a week, started feeling similar symptoms in Left extremity. No shoulder/neck pain. Pain starts at the deltoid at the injection site and has caused stiffness, pain, and tightness of the upper extremities alone. Decreased grip b/l. Symptoms have persisted since ( almost a month now) but did seem to resolve while on prednisone, but returned after cessation.   No respiratory issues, chest pain, paresthesias, or lower extremity symptoms.
No Adverse event; a lot of the vaccine ran down my arm to my elbow; It was a partial dose that I got./I'm concerned that I didn't get the full dose; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE DISCHARGE (a lot of the vaccine ran down my arm to my elbow), ACCIDENTAL UNDERDOSE (It was a partial dose that I got./I'm concerned that I didn't get the full dose) and NO ADVERSE EVENT (No Adverse event) in a 56-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 059F22A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.    On 19-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 19-Oct-2022, the patient experienced VACCINATION SITE DISCHARGE (a lot of the vaccine ran down my arm to my elbow) and ACCIDENTAL UNDERDOSE (It was a partial dose that I got./I'm concerned that I didn't get the full dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, VACCINATION SITE DISCHARGE (a lot of the vaccine ran down my arm to my elbow), ACCIDENTAL UNDERDOSE (It was a partial dose that I got./I'm concerned that I didn't get the full dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessments were provided for VACCINATION SITE DISCHARGE (a lot of the vaccine ran down my arm to my elbow) and ACCIDENTAL UNDERDOSE (It was a partial dose that I got./I'm concerned that I didn't get the full dose).    Patient received the 5th dose of Moderna Covid-19 Vaccine, Bivalent about 40 min ago.  It was reported that When the student nurse pulled the needle out, a lot of the vaccine ran down patient arm to her elbow. It was a partial dose that patient got. patient was concerned & asked her about it. She then went to ask someone else, & that person said 'it'll be ok. You'll still get the full effect.  Patient taken 5 different immunosuppressants. patient was concerned that  patient didn't get the full dose. And immunocompromised people don't ever get the full effect of vaccines anyway.   Patient received First dose on 24-Jan-2021 with Lot number 027L20A. Patient received second dose on 24-Feb-2021 with Lot number 032L20A. Patient received First  booster dose on 21-Aug-2021 with Lot number 52C21A. Patient received second booster dose on 18-Feb-2022 with Lot number 025L21B.  No treatment drug were reported.   This case was linked to MOD-2022-661309 (Patient Link).
I'm a healthy athletic 30 year old female and I've always had regular, on-time periods. My period was due June 7th and my second vaccine shot was May 25th. I am now almost two weeks late and not pregnant. I've been having premenstrual symptoms now for the entire two weeks including sore, swollen breasts, cramping, and bloating. It's like my body is expecting my period to start any day now but it's not. Two days ago while I was brushing my teeth and getting ready for work, I suddenly got the worst sharp pains in my pelvic region and rectum to the point that I couldn't stand. I had to lay down for an hour. I've never felt anything like that before. I'm a very healthy & stress free individual that does not take any medication (birth control, over the counter meds, etc.) The Pfizer vaccine is the only "new" thing to come into my body.
I did not have an adverse reaction to the Pfizer Bivalent vaccine.  I woke up on 12/17/2022 and was walking down the hallway towards my kitchen and passed out three times. I went to the emergency room for observation and admitted for three days to the COVID-19 ward. I tested positive for COVID-19 on 12/17/2022. My electrolytes and potassium were very low which is why I passed out and at danger for cardiac arrest.  It took about a month to gain my strength. As of today, I feel better with no lingering symptoms.
Injection Site Reactions included: pain, tenderness and swelling of the lymph nodes in the same arm of the injection (left arm) and hardness and some swelling around injection area of said left arm. Started on Wednesday, December 23, 2020 at approximately 5;30 pm and is still ongoing as of December 26, 2020 at time of this report.   General Side Effects: Fatigue: Started on Wednesday, December 23, 2020 at approximately 5:30 pm and is still ongoing Muscle Pain, Joint Pain, Chills and Nausea: Started on Wednesday, December 23, 2020 at approximately 5:30 pm and subsided on December 25  at approximately 6 am. headaches and sporadic fevers: Started on Wednesday, December 23, 2020 at approximately 5:30 pm and is still ongoing -  taking ibuprofen to keep fever and headaches down.
Information has been received from a pharmacist concerning an adult female client with an unk previous vaccination history who was vaccinated (date not reported) with a dose of pneumococcal 23v polysaccharide vaccine (lot unk). Subsequently the client experienced a severe local site reaction and induration the size of a softball. It was reported that the client sought unspecified medical attention. No other information was available at the time of call. There was no product quality complaint involved. It was reported that two other adult females experienced local site reactions and induration after administration of pneumococcal 23v polysaccharide vaccine (lot unk) (WAES0502USA00004 and 0502USA00005). Additional information has been requested.
Vaccines admin Afternoon of 11/16/06. Mother reports redness and swelling from hip to knee (lateral thigh). Child was very fussy. Mom applied ice that evening. When child woke in AM 11/17/06 only small bruise remained. Activity was wnl at this time.
Normal side effects began after my second vaccination. Soreness of arm, fatigue, diarrhea, headache, chills and feverish. After about 24 hours later had full body sweats and chills, intense chest pain, shortness of breath, nausea and diarrhea. I called my primary care after hours and was told to go to the emergency room due to these symptoms.
Immediately with the administration of the vaccine I had a shooting tingling/numbness/pain that went from the injection site down my arm to my fingers.  The sensation worsened and became more painful accompanied by a weakness in my right arm.  I went my primary care physician to have this looked at.  My injection was nearly 3.5 months ago and I still continue to experience the same symptoms. I have ongoing pain/weakness down my entire right arm.
2 DAYS AFTER VACCINE PATIENT NOTICED A SMALL BUMP ON HIS SIDE. THIS HAS TURNED INTO BUMPS ALL OVER HIS BODY. THE PT REPORTS THAT THE BUMPS ARE ITCHY AND HAVE SOME FLUID. HE REPORTS THAT THE FLUID BUMPS LAST A COUPLE OF DAYS AND THEN SCAB OVER. THE PT HAS HAD CHICKEN POX AND HAS BEEN VACCINATED.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 01-APR-2015 the patient was vaccinated with one dose of VARIVAX (Merck) (dose and route of administration were not reported, lot # K020758 with expiration date: 31-OCT-2016) which was improperly stored. No adverse effects were reported. Additional information has been requested.
Three hours post vax, the pt experienced intense joint pain, headache, fever, occasional nausea and weakness. She continued to have joint pain on and off. Fever and nausea resolved. She took aspirin for the pain.